Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
New Business Partnership Between Otsuka Pharmaceutical and Digital Health VR Technology Developer Jolly Good
2022-02-01 21:00
Cytiva fuels biotech development in Australia and New Zealand
2022-02-01 07:00
DEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA
2022-02-01 06:00
Denovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD)
2022-02-01 05:30
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
2022-02-01 04:06
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement
2022-01-31 19:00
HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital
2022-01-29 11:37
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China
2022-01-29 05:28
CTB001, Bioheng auto CAR - T Product, received Orphan Drug Designation (ODD) from the U.S. FDA
2022-01-28 22:00
I-Mab Announces Partnership Agreement to Localize Manufacturing and Accelerate Commercialization of Innovative Biologics Drugs
2022-01-28 21:00
Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis
2022-01-28 08:10
Ractigen Therapeutics closes an additional $30 million in Series A+ funding to push development of its RNAa platform
2022-01-27 22:10
FDA Grants Breakthrough Therapy Designation for Dizal Pharmaceutical's DZD9008 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon20 Insertion
2022-01-27 21:15
Brii Bio Appoints Karen D. Neuendorff as Chief People Officer and Head of Human Resources
2022-01-27 21:00
Exyte Closes 2021 with Record Order Intake
2022-01-27 20:53
KLӦCKNER PENTAPLAST COMMITS TO rPET/PET CAPACITY EXPANSION FOR THE SUSTAINABLE HEALTHCARE AND FOOD PACKAGING MARKET IN NORTH AMERICA
2022-01-27 20:00
Adlai Nortye Announces Global License-out Agreement with Biotime for Several Products Including PD-L1 Inhibitor (AN4005) and Anti-hTNFR2 Antibody (AN3025)
2022-01-26 21:00
Ascletis Announces IND Filing of Its Second FASN Inhibitor ASC60 for Advanced Solid Tumors Accepted by China NMPA
2022-01-26 19:00
Singapore Grants Approval for INDICAID COVID-19 Rapid Antigen Test as Consumer Self-test for SARS-CoV-2 Control
2022-01-26 17:18
GenScript ProBio Initiates a CDMO Contract For Next-Generation CD47 Antibody with InnoBation Bio
2022-01-26 09:00
1
197
198
199
200
201
416